ATE484508T1 - Furylverbindungen - Google Patents
FurylverbindungenInfo
- Publication number
- ATE484508T1 ATE484508T1 AT03746523T AT03746523T ATE484508T1 AT E484508 T1 ATE484508 T1 AT E484508T1 AT 03746523 T AT03746523 T AT 03746523T AT 03746523 T AT03746523 T AT 03746523T AT E484508 T1 ATE484508 T1 AT E484508T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- furyl compounds
- furyl
- compositions
- therapy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201186A SE0201186D0 (sv) | 2002-04-18 | 2002-04-18 | Furyl compounds |
| SE0203607A SE0203607D0 (sv) | 2002-12-04 | 2002-12-04 | Furyl compounds |
| PCT/SE2003/000613 WO2003087102A1 (en) | 2002-04-18 | 2003-04-15 | Furyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE484508T1 true ATE484508T1 (de) | 2010-10-15 |
Family
ID=29253788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03746523T ATE484508T1 (de) | 2002-04-18 | 2003-04-15 | Furylverbindungen |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7417049B2 (de) |
| EP (1) | EP1499618B1 (de) |
| JP (1) | JP4511195B2 (de) |
| KR (1) | KR20040099447A (de) |
| CN (1) | CN1325500C (de) |
| AT (1) | ATE484508T1 (de) |
| AU (1) | AU2003225456B2 (de) |
| BR (1) | BR0309343A (de) |
| CA (1) | CA2482311C (de) |
| DE (1) | DE60334536D1 (de) |
| IL (1) | IL164509A0 (de) |
| MX (1) | MXPA04010191A (de) |
| NO (1) | NO20044996L (de) |
| NZ (1) | NZ561794A (de) |
| WO (1) | WO2003087102A1 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| CA2462453C (en) | 2001-10-02 | 2009-07-28 | Pharmacia & Upjohn Company | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| ES2348282T3 (es) * | 2002-04-18 | 2010-12-02 | Astrazeneca Ab | Compuestos de tienilo. |
| BRPI0415546A (pt) | 2003-10-21 | 2006-12-26 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios |
| US7045530B2 (en) | 2003-12-22 | 2006-05-16 | Abbott Laboratories | Spirocyclic quinuclidinic ether derivatives |
| TW200813067A (en) | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
| SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| CN102131791B (zh) | 2008-06-20 | 2014-12-24 | 阿斯利康(瑞典)有限公司 | 二苯并硫杂氮杂*衍生物及其用途 |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| PE20170923A1 (es) | 2010-05-17 | 2017-07-12 | Forum Pharmaceuticals Inc | Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidratado |
| MX337106B (es) | 2010-05-27 | 2016-02-12 | Targacept Inc | Antagonistas no competitivos de receptores nicotinicos. |
| GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
| GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
| JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
| EP3461481A1 (de) | 2012-05-08 | 2019-04-03 | Forum Pharmaceuticals Inc. | Verfahren zur aufrechterhaltung, behandlung oder verbesserung der kognitiven funktion |
| GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
| JP6478923B2 (ja) | 2013-02-07 | 2019-03-06 | ヘプタレス セラピューティクス リミテッドＨｅｐｔａｒｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート |
| WO2014202999A1 (en) | 2013-06-21 | 2014-12-24 | Takeda Cambridge Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
| GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
| GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
| GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
| TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
| EP3215512A1 (de) * | 2014-11-04 | 2017-09-13 | Bristol-Myers Squibb Company | Chinuclidin-verbindungen als alpha-7-nikotin-acetylcholin-rezpetorliganden |
| GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
| CN108003895B (zh) * | 2016-10-28 | 2019-04-19 | 西安近代化学研究所 | 一种向列相液晶组合物及其显示元件 |
| CN108018049B (zh) * | 2016-10-28 | 2019-09-27 | 西安近代化学研究所 | 具有5,6-二氟取代苯并呋喃环的液晶化合物 |
| GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
| JP7260564B2 (ja) | 2018-05-10 | 2023-04-18 | ゾエティス・サービシーズ・エルエルシー | 内部寄生性デプシペプチド |
| JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
| GB202414197D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202414193D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
| FR2788982B1 (fr) * | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
| US6569865B2 (en) * | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
| BR0210075A (pt) | 2001-06-01 | 2004-08-17 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa |
| ES2348282T3 (es) * | 2002-04-18 | 2010-12-02 | Astrazeneca Ab | Compuestos de tienilo. |
-
2003
- 2003-04-15 US US10/511,535 patent/US7417049B2/en not_active Expired - Fee Related
- 2003-04-15 KR KR10-2004-7016547A patent/KR20040099447A/ko not_active Ceased
- 2003-04-15 MX MXPA04010191A patent/MXPA04010191A/es active IP Right Grant
- 2003-04-15 BR BR0309343-3A patent/BR0309343A/pt not_active IP Right Cessation
- 2003-04-15 JP JP2003584058A patent/JP4511195B2/ja not_active Expired - Fee Related
- 2003-04-15 WO PCT/SE2003/000613 patent/WO2003087102A1/en not_active Ceased
- 2003-04-15 DE DE60334536T patent/DE60334536D1/de not_active Expired - Lifetime
- 2003-04-15 AU AU2003225456A patent/AU2003225456B2/en not_active Ceased
- 2003-04-15 CN CNB038138956A patent/CN1325500C/zh not_active Expired - Fee Related
- 2003-04-15 CA CA002482311A patent/CA2482311C/en not_active Expired - Fee Related
- 2003-04-15 EP EP03746523A patent/EP1499618B1/de not_active Expired - Lifetime
- 2003-04-15 NZ NZ561794A patent/NZ561794A/en unknown
- 2003-04-15 AT AT03746523T patent/ATE484508T1/de not_active IP Right Cessation
-
2004
- 2004-10-11 IL IL16450904A patent/IL164509A0/xx unknown
- 2004-11-17 NO NO20044996A patent/NO20044996L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1499618A1 (de) | 2005-01-26 |
| CN1325500C (zh) | 2007-07-11 |
| NZ561794A (en) | 2008-11-28 |
| MXPA04010191A (es) | 2005-02-03 |
| EP1499618B1 (de) | 2010-10-13 |
| CA2482311A1 (en) | 2003-10-23 |
| AU2003225456B2 (en) | 2009-02-05 |
| DE60334536D1 (de) | 2010-11-25 |
| IL164509A0 (en) | 2005-12-18 |
| US7417049B2 (en) | 2008-08-26 |
| CA2482311C (en) | 2009-12-08 |
| KR20040099447A (ko) | 2004-11-26 |
| US20050176745A1 (en) | 2005-08-11 |
| JP4511195B2 (ja) | 2010-07-28 |
| WO2003087102A1 (en) | 2003-10-23 |
| JP2005533012A (ja) | 2005-11-04 |
| NO20044996L (no) | 2005-01-18 |
| AU2003225456A1 (en) | 2003-10-27 |
| CN1662541A (zh) | 2005-08-31 |
| HK1079519A1 (en) | 2006-04-07 |
| BR0309343A (pt) | 2005-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE484508T1 (de) | Furylverbindungen | |
| NO20044995L (no) | Heterosykliske forbindelser | |
| DE60333746D1 (de) | Thienylverbindungen | |
| SE0401971D0 (sv) | Piperidne derivatives | |
| SE0101387D0 (sv) | Novel compounds | |
| IS7721A (is) | Píperidín-pýrídasón og þalasón sem PDE4 hemlar | |
| SE0202463D0 (sv) | Novel compounds | |
| SE0401970D0 (sv) | Novel compounds | |
| EA200501009A1 (ru) | Замещённые пирролопиразольные производные в качестве ингибиторов киназы | |
| MX2007005933A (es) | Compuestos de acetamida como fungicidas. | |
| EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
| SE0302139D0 (sv) | Novel compounds | |
| DK1483251T3 (da) | C3-cyano-epothilon-derivater | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
| SE0203303D0 (sv) | Novel Compounds | |
| EA200600100A1 (ru) | Производные никотинамида, полезные в качестве ингибиторов pde4 | |
| DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
| SE0203300D0 (sv) | Novel Compounds | |
| EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
| DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
| SE0203302D0 (sv) | Novel Compounds | |
| NO20030500L (no) | Dihydroporfyrinderivater og deres anvendelse | |
| DK1638948T3 (da) | Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |